What is the 13F Pro Quality Score for HCA?

13F Pro ranks HCA Healthcare, Inc. (HCA) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View HCA's current score at https://13fpro.ai/company/HCA (free sign-up required for the full ranking).

Which hedge funds own the most HCA stock?

Based on the most recent Form 13F-HR filings on SEC EDGAR, the largest reported institutional holders of HCA include BlackRock,, VANGUARD CAPITAL MANAGEMENT, Sanders Capital,. Holdings are reported quarterly within 45 days of quarter-end and updated on https://13fpro.ai/company/HCA as soon as new 13F filings post.

Where does 13F Pro source HCA data?

All HCA Healthcare, Inc. fundamentals and ownership data come directly from SEC EDGAR. HCA Healthcare, Inc. files with the SEC under CIK 860730. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is HCA in?

HCA Healthcare, Inc. (HCA) is classified in the Healthcare sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/healthcare.

What drives HCA's revenue?

Per HCA Healthcare, Inc.'s latest 10-Q filed with the SEC on 2026-07-28, the biggest revenue drivers are: Atlantic Group ($7,573M); American Group ($6,582M); National Group ($5,251M). Figures are extracted from the filing text and machine-verified against the document. Full breakdown at https://13fpro.ai/company/HCA.

How often is HCA research updated on 13F Pro?

HCA's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

HCA Healthcare, Inc.(HCA)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Healthcare →NYSElarge

Institutional-grade research for retail investors

SEC EDGAR: CIK 860730 HCA stock profile & AI dashboard →

13F Pro Quality Score

68.9/100

Rank #292 of 2,961 stocksTOP 10%

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Revenue Growth

50.0/100

Profitability

62.0/100

Balance Sheet

87.5/100

Earnings Quality

82.7/100

Free Cash Flow

56.5/100

Institutional Flow

51.4/100

Revenue Scale

97.9/100

Dilution Risk

73.9/100

Email me the moment this company reports earnings

AI Research Report

Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.

Upgrade to Pro

Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

Why HCA Scores 69/100

exact factor attribution · 2026-09-11

HCA's composite is driven by scale and capital efficiency. Bars show each factor's exact push vs. a median company, using the same weights the ranking engine applies.

Scale

+7.2 pts

98th pct

Capital efficiency

+3.8 pts

88th pct

Earnings quality

+3.3 pts

83th pct

Profitability

+1.8 pts

62th pct

Shareholder dilution

+1.2 pts

74th pct

Free cash flow

+1.0 pts

57th pct

Earnings growth

+0.6 pts

62th pct

Institutional flow

+0.1 pts

51th pct

Revenue growth

+0.0 pts

50th pct

Factor percentiles are cross-sectional ranks across the ~2,800-stock scored universe, computed from SEC EDGAR filings. Not investment advice.

HCA Stock Analysis & AI Quality Score

Data updated 2026-09-11

AI stock analysis and institutional research for HCA Healthcare, Inc. (HCA), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores HCA at 68.9/100 on a 32-signal composite quality model, placing it at rank #292 of 2,961 stocks — the top 10% of the AI-ranked universe. HCA scores in the top quartile across revenue scale (97.9), balance sheet strength (87.5), earnings quality (82.7). Based on the latest XBRL financial filings (Q1 2026), HCA Healthcare, Inc. reports quarterly revenue of $19.1B, net income of $1.6B, an operating margin of 12.0%. Top institutional holders of HCA by reported 13-F value include BlackRock, VANGUARD CAPITAL MANAGEMENT, Sanders Capital, based on the most recent SEC filings. HCA trades on the NYSE exchange and files with the SEC under CIK 860730. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate HCA daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for HCA Healthcare, Inc. directly from SEC EDGAR. HCA Healthcare, Inc.'s 13F Pro composite quality score has ranged between 58 and 73 since 2021, currently 68.9 — a declining long-term trajectory across 67 quarterly and live scoring snapshots.

What's Driving HCA's Business? Latest 10-Q Breakdown

✓ 43/43 datapoints verified

AI-extracted from HCA Healthcare, Inc.'s 10-Q filed 2026-07-28 — Q2 2026 (quarter ended June 30, 2026). Every figure is machine-verified against the filing text on SEC EDGAR.

Revenues rose 8.7% to $20.230B, but $1.372B of incremental Florida Medicaid directed payment revenue — $980M tied to prior periods — flattered the quarter.

Biggest Revenue Drivers

Atlantic Group$7,573M

Florida-heavy group; adjusted segment EBITDA rose to $1,827M from $1,352M

American Group$6,582M

Adjusted segment EBITDA declined to $1,369M from $1,578M

Biggest Revenue Drivers

Total revenue: $20.230B+8.7% YoY

Atlantic Group$7,573M

Florida-heavy group; adjusted segment EBITDA rose to $1,827M from $1,352M

American Group$6,582M

Adjusted segment EBITDA declined to $1,369M from $1,578M

National Group$5,251M

Adjusted segment EBITDA declined to $1,184M from $1,271M

Corporate and other$824M

Includes the seven hospitals operated in England

Largest Expense Items

Salaries and benefits$8,290M41.0% of revenues vs 43.7%

Salaries and benefits per equivalent admission declined 0.7%; same facility per full-time equivalent rose 2.5%

Other operating expenses$5,043M24.9% of revenues vs 20.4%

Primarily growth in Medicaid state directed and supplemental payment program expenses and professional fees

Supplies$2,886M14.3% of revenues vs 15.3%

Supply cost per equivalent admission declined 1.0%; pharmacy supplies down 5.0% on lower drug utilization

Depreciation and amortization$944M+$81M YoY

Increase relates primarily to capital expenditures at existing facilities

Margins: Income before income taxes fell to 12.3% of revenues from 13.0%. Lower salaries (41.0% vs 43.7%) and supplies (14.3% vs 15.3%) ratios were more than offset by other operating expenses at 24.9% vs 20.4%.

Watch Items from the Filing

Q2 included $1.372B incremental revenues and $829M other operating expenses from the Florida directed payment program; ~$980M of revenues related to periods prior to 2026.
Consolidated uninsured admissions rose 23.3% after enhanced premium tax credits expired; estimated cost of uncompensated care rose to $1.445B from $1.116B.
103 hospitals in Texas and Florida generated 58% of admissions and 55% of revenues, and 73% of uninsured admissions.
Managed care and insurers revenue fell to $9,013M from $9,124M, unfavorably impacted by EPTC expiration and Exchange administrative reforms.
Debt totaled $49.718B with quarterly interest expense of $599M; second-quarter operating cash flow fell $1.875B to $2.335B on Medicaid receivables and tax timing.

AI-extracted and verified against SEC EDGAR filing text. Not investment advice.

Read the full 10-Q on SEC EDGAR →Share on X

Revenue

Q1 2026

$19.1B

Net Income

Q1 2026

$1.6B

Free Cash Flow

Q1 2026

$895.0M

Operating Margin

Q1 2026

12.0%

ROIC

Q1 2026

21.9%

Period

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro

Revenue

+7.1% YoY

$75.60BFY 2025

FY22 $60.23BFY23 $64.97BFY24 $70.60BFY25 $75.60B

Net Income

+17.8% YoY

$6.78BFY 2025

FY22 $5.64BFY23 $5.24BFY24 $5.76BFY25 $6.78B

EPS (Diluted)

+28.8% YoY

$28.33FY 2025

FY22 $19.15FY23 $18.97FY24 $22.00FY25 $28.33

Total Assets

+2.0% YoY

$60.72BFY 2025

FY22 $52.44BFY23 $56.21BFY24 $59.51BFY25 $60.72B

Total Debt

+8.0% YoY

$46.49BFY 2025

FY22 $38.45BFY23 $42.02BFY24 $43.03BFY25 $46.49B

Op. Cash Flow

+20.2% YoY

$12.64BFY 2025

FY22 $8.52BFY23 $9.43BFY24 $10.51BFY25 $12.64B

Free Cash Flow

+36.4% YoY

$7.69BFY 2025

FY22 $4.13BFY23 $4.69BFY24 $5.64BFY25 $7.69B

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Revenue	$75.60B +7.1%	$70.60B +8.7%	$64.97B +7.9%	$60.23B +2.5%	$58.75B +14.0%	$51.53B
Net Income	$6.78B +17.8%	$5.76B +9.9%	$5.24B -7.1%	$5.64B -18.9%	$6.96B +85.3%	$3.75B
EPS (Diluted)	$28.33 +28.8%	$22.00 +16.0%	$18.97 -0.9%	$19.15 -9.5%	$21.16 +93.6%	$10.93
Total Assets	$60.72B +2.0%	$59.51B +5.9%	$56.21B +7.2%	$52.44B +3.3%	$50.74B +6.8%	$47.49B
Total Debt	$46.49B +8.0%	$43.03B +2.4%	$42.02B +9.3%	$38.45B +10.4%	$34.82B +11.5%	$31.21B
Operating Cash Flow	$12.64B +20.2%	$10.51B +11.5%	$9.43B +10.7%	$8.52B -4.9%	$8.96B -3.0%	$9.23B
Free Cash Flow	$7.69B +36.4%	$5.64B +20.3%	$4.69B +13.6%	$4.13B -23.3%	$5.38B -15.9%	$6.40B

Get alerted when HCA's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for HCA Healthcare, Inc. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of HCA

BlackRock, Inc.
$5.1B13,003,600 sh
VANGUARD CAPITAL MANAGEMENT LLC
$4.0B10,141,708 sh
Sanders Capital, LLC
$3.4B8,828,287 sh
STATE STREET CORP
$2.9B7,469,035 sh
WELLINGTON MANAGEMENT GROUP LLP
$1.8B4,707,473 sh
GEODE CAPITAL MANAGEMENT, LLC
$1.4B3,668,008 sh
First Eagle Investment Management, LLC
$1.3B3,295,565 sh
VANGUARD PORTFOLIO MANAGEMENT LLC
$1.1B2,712,828 sh
MORGAN STANLEY
$1.0B2,586,771 sh
GOLDMAN SACHS GROUP INC
$960.8M2,464,314 sh

Fund	Value	Shares
BlackRock, Inc.	$5.1B	13,003,600
VANGUARD CAPITAL MANAGEMENT LLC	$4.0B	10,141,708
Sanders Capital, LLC	$3.4B	8,828,287
STATE STREET CORP	$2.9B	7,469,035
WELLINGTON MANAGEMENT GROUP LLP	$1.8B	4,707,473
GEODE CAPITAL MANAGEMENT, LLC	$1.4B	3,668,008
First Eagle Investment Management, LLC	$1.3B	3,295,565
VANGUARD PORTFOLIO MANAGEMENT LLC	$1.1B	2,712,828
MORGAN STANLEY	$1.0B	2,586,771
GOLDMAN SACHS GROUP INC	$960.8M	2,464,314

Companies Similar to HCA

Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.

DGX

QUEST DIAGNOSTICS INC

AI score

Very similar · 25 shared holders

PFA Pension, Forsikringsaktieselskab SEB Asset Management AB APG Asset Management N.V.

SYK

STRYKER CORP

AI score

Very similar · 20 shared holders

NORDEA INVESTMENT MANAGEMENT AB National Pension Service ROYAL LONDON ASSET MANAGEMENT LTD

ABT

ABBOTT LABORATORIES

AI score

Very similar · 33 shared holders

Capital International Investors National Pension Service Sanders Capital, LLC

CVS

CVS HEALTH Corp

AI score

Very similar · 39 shared holders

Capital World Investors Capital International Investors LSV ASSET MANAGEMENT

UNH

UNITEDHEALTH GROUP INC

AI score

Very similar · 32 shared holders

Sanders Capital, LLC Capital World Investors Capital International Investors

LABCORP HOLDINGS INC.

AI score

Very similar · 30 shared holders

NORDEA INVESTMENT MANAGEMENT AB BRANDES INVESTMENT PARTNERS, LP COOKE & BIELER LP

MDT

Medtronic plc

AI score

Very similar · 29 shared holders

First Eagle Investment Management, LLC Capital World Investors National Pension Service

BSX

BOSTON SCIENTIFIC CORP

AI score

Very similar · 30 shared holders

Capital World Investors National Pension Service NORDEA INVESTMENT MANAGEMENT AB

Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.

More Healthcare Companies

View all Healthcare →

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

AARD

Aardvark Therapeutics, Inc.

ABBV

AbbVie Inc.

ABCL

AbCellera Biologics Inc.

ABEO

ABEONA THERAPEUTICS INC.

ABOS

Acumen Pharmaceuticals, Inc.

ABPWW

Abpro Holdings, Inc.

ABSI

Absci Corp

Put HCA on your watchlist

Track score changes the day HCA Healthcare, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is HCA a good stock to buy?

13F Pro's AI-powered analysis of HCA Healthcare, Inc. (HCA) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for HCA are available on the HCA stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. HCA is classified as a large company.

Which hedge funds own HCA?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling HCA. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of HCA Healthcare, Inc.'s investment landscape.